Safety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease Patients
NCT01747980
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Gaucher Disease
Interventions
DRUG:
PRX-112
Sponsor
Protalix